ARTICLE |
a Immunization Program, Chicago Department of Public Health, Chicago, Illinois
b Collaborative Research Unit, Cook County Hospital, Chicago, Illinois
| ABSTRACT |
|---|
|
|
|---|
METHODS. In 1997, the Illinois Department of Public Health mandated hepatitis B vaccination before entry into 5th grade. We conducted a retrospective cohort study of 6 consecutive Chicago public schools 12th-grade classes; 4 entered 5th grade before the mandate (premandate cohorts) and 2 afterward (postmandate cohorts). We used Chicago public schools vaccination database and calculated annual coverage levels for 2nd through 12th grades; the cohorts entered 12th grade during 2000–2005. We compared hepatitis B vaccination coverage levels according to race/ethnicity and coverage levels for the premandate and postmandate cohorts.
RESULTS. We evaluated 106 541 students. The postmandate cohort had significantly higher hepatitis B vaccination coverage levels than the premandate cohort at 5th-grade (38.2% vs 4.3%) and 9th-grade (85.0% vs 37.4%) entry. For 9th-grade students, compared with white students, black students were less likely to have received hepatitis B vaccination before the mandate; this disparity decreased for the first postmandate cohort. For Hispanic students, the disparity was less pronounced and also decreased after the mandate. By 9th grade in the postmandate cohorts, coverage levels for all racial/ethnic groups exceeded 80%.
CONCLUSIONS. There was a dramatic decrease in the disparity of hepatitis B vaccination coverage between white and black or Hispanic students. School-entry requirements effectively increased hepatitis B vaccination coverage levels regardless of race or ethnicity and should be considered for other recently recommended adolescent vaccines.
Key Words: hepatitis B vaccine adolescent immunization schools
Abbreviations: ACIP—Advisory Committee on Immunization Practices AAP—American Academy of Pediatrics AAFP—American Academy of Family Physicians HBV—hepatitis B vaccination MMR—measles-mumps-rubella CI—confidence interval HPV—human papillomavirus
In 1994, to reduce more rapidly the incidence of hepatitis B virus infection, the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) approved a recommendation to expand hepatitis B vaccination (HBV) of infants to include routine vaccination of 11- to 12-year-old adolescents.1 Two years later, to increase vaccination coverage against hepatitis B, measles-mumps-rubella (MMR), and varicella infections and to provide a tetanus-diphtheria booster to adolescents, the ACIP, AAP, AAFP, and the American Medical Association recommended a routine health care visit for 11- to 12-year-old patients.2 After these recommendations, results from subsequent National Health Interview Surveys indicated that adolescent coverage levels increased but remained below the Healthy People 2010 objective of 90%.3 In addition to falling short of target coverage levels, there is evidence of substantial racial, ethnic, and gender differences in adolescent vaccination coverage levels.4,5
State vaccination laws and regulations for kindergarten entry are effective in attaining high coverage levels (>90%) among school attendees and have led to a marked decline in morbidity and mortality from vaccine-preventable diseases.6,7 These laws also serve as an effective "safety net" because they apply to all children who enter school, regardless of race, ethnicity, socioeconomic status, or insurance coverage.6,8 State laws that require proof of vaccination for entry into middle school have resulted in increased adolescent vaccination coverage levels9–11; however, the effect of middle school-entry requirements on racial and ethnic disparities is unknown.
Before the 1997 school year, the Illinois Department of Public Health approved a requirement for completion of
3 doses of hepatitis B vaccine by entry into 5th grade. We describe the effect of the requirement on racial and ethnic disparities in adolescent hepatitis B vaccine coverage levels using data from 6 cohorts of Chicago public schools students; 4 cohorts entered 5th grade before the requirement, and 2 cohorts entered 5th grade after the requirement.
| METHODS |
|---|
|
|
|---|
We extracted data for 6 cohorts of Chicago public schools students; each cohort was composed of students in 12th grade for 6 consecutive years, 2000 through 2005. Retrospective hepatitis B coverage levels were determined for each cohort back to 2nd grade. For eligibility for inclusion in the cohort, we required students to be enrolled in the Chicago public schools system during 12th grade. We identify each cohort by the year that the students entered 5th grade. We evaluated 4 cohorts that entered 5th grade before the requirement (1993–1996; ie, premandate cohorts) and 2 cohorts that entered 5th grade after the requirement (1997–1998; ie, postmandate cohorts). Students were retained in the cohort to which they were assigned on the basis of entry into 12th grade regardless of whether they advanced a grade in each academic year.
State Requirement
Illinois requires that students complete the HBV series before October 15 of their 5th-grade year. After this date, students may be excluded from school if they cannot provide documentation of having completed or initiated the vaccine series. Students who have medical contraindications to vaccination (infection with hepatitis B virus or serious allergy to the vaccine or 1 of its components) or religious beliefs that do not allow them to be vaccinated are permanently exempted from vaccination requirements. To allow students who are in the process of completing a multiple-dose vaccination series to continue attending school, nurses and administrators are allowed to temporarily exempt students for 1 year.
Coverage-Level Determination
We calculated annual coverage levels for each cohort by determining the proportion of students who had received
3 doses of hepatitis B vaccine by October 15 of the year assessed (eg, 5th-grade students in the 1993 cohort who had received
3 doses of hepatitis B vaccine by October 15, 1993, were considered vaccinated). We also evaluated coverage levels stratified according to racial/ethnic group. Because we were provided dates at the level of the month and year, we imputed every birth and vaccination date as the 15th of the month.
To examine the effects of the 5th-grade entry requirement on racial and ethnic coverage levels, we compared vaccination coverage levels for the 4 premandate cohorts and the 2 postmandate cohorts. Because heterosexual or homosexual transmission accounts for >60% of hepatitis B infections among adults in the United States13 and because
25% of 9th-graders report having had vaginal sex,14 we report coverage levels at entry into 9th grade for white, black, and Hispanic students. For the students who were enrolled in 5th grade 1 year before (ie, the 1996 cohort) and for 2 years after implementation of the 5th-grade vaccination requirement (ie, the 1997 and 1998 cohorts), we report the risk ratios and 95% confidence intervals (CIs) for completion of the hepatitis B vaccine series at 5th- and 9th-grade entry. We compared black or Hispanic students with white students (ie, the referent group). Because of the relatively small percentage of Asian/Pacific Islander and Native American students enrolled in Chicago public schools, we limited our analyses to white, black, and Hispanic students. We compared vaccination coverage levels between white and black or Hispanic students using the
2 test. We used SAS 9.1.3 statistical software (SAS Institute, Inc, Cary, NC) for all statistical analyses; all P values were 2-sided.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The existence of racial and ethnic disparities in vaccination coverage levels among adolescents is not surprising. Among preschool children, local evaluations of vaccination coverage levels in Chicago have consistently found that compared with other racial and ethnic groups, black children have the lowest vaccination coverage levels.12,16,17 The factors that contributed to low vaccination coverage levels among black preschool children (eg, poor access to vaccinations, suboptimal record-keeping)18 are likely to persist through adolescence. In addition to the previously mentioned factors, the following adolescent-specific barriers complicate efforts to identify and vaccinate individuals who were missed at an earlier age: the nadir of medical visits occurs during 15 through 24 years of age,19 and parental consent may be difficult to obtain in settings where adolescents are unaccompanied by parents (eg, school-based vaccination program).20
Although for childhood vaccinations a kindergarten school-entry requirement was considered to be a critical factor in improving coverage levels among black children,16 the reduction in racial disparities occurs several years after the recommended age of vaccination, which results in a period of increased risk for disease; however, the increase in HBV coverage levels for all racial and ethnic groups occurs by 9th grade, which protects most vaccine recipients before the onset of sexual activity, the most common mode of hepatitis B transmission.13
Our findings are particularly relevant to health care providers, public health professionals, and legislators who seek strategies to achieve goals for adolescent coverage levels for other vaccines. For example, 6th-grade vaccination requirements for 3 recently recommended vaccinations for adolescents (Meningococcus, tetanus, diphtheria and acellular pertussis, and human papillomavirus [HPV]) should help meet target vaccination levels while alleviating possible racial and ethnic disparities in vaccination coverage levels.
The effect of school-entry requirements on HBV levels is particularly relevant to the successful prevention of cervical cancer through HPV vaccination. For example, both hepatitis B and HPV vaccines require 3 doses, which necessitates several visits to health care providers and monitoring the timing and number of doses administered. Despite these challenges, we found that hepatitis B vaccine series completion levels by 9th grade for all racial and ethnic groups were >80% for the first cohort and >88% for the second cohort of students affected by the school-entry requirement. Because of the similarities in vaccination schedules and age of vaccination, it may be possible to extrapolate the success of the HBV requirement to the HPV vaccine, which likely would result in rapidly increased HPV vaccine coverage levels for all racial and ethnic groups. Acquisition of HPV infection usually occurs within the first few years after sexual initiation,21 and the percentage of people who report having vaginal sex increases from 25% in 9th grade to 75% in 12th grade.14 In our study, the vaccination coverage levels had already increased dramatically by 9th grade; school-entry requirements for the HPV vaccine also should result in protection for the majority of adolescents. Because compared with white women, black and Hispanic women have a higher incidence of and mortality from cervical cancer,22 it is critical that the HPV vaccine be equitably distributed to white, black, and Hispanic adolescents.
Although additional middle school vaccination requirements are likely to reduce substantially the morbidity from vaccine-preventable diseases, we have learned from the HBV school-entry requirement that several preliminary actions will facilitate public acceptance of the requirements. Activities that improve vaccine acceptance include community and provider education, expanded access to vaccinations, provider and patient reminders, and increased use of patient-held vaccination records.23 In Illinois, the 5th-grade HBV requirement was enacted 3 years after the ACIP, AAP, and AAFP issued their recommendation for routine HBV of adolescents. As a result, many programs to educate the community and health care providers and to increase access to immunizations (eg, provision of vaccine for insured, uninsured, and underinsured children; school-based vaccination drives) had been initiated before the school-entry requirement was implemented.
Disadvantages of premature adoption of school-entry requirements include potential opposition from health care providers and the public, who would likely have been supportive at a later time, and challenges to health care and school systems from having to vaccinate large numbers of students in a short period of time. In Chicago, school-entry requirements were effective in achieving high vaccination coverage levels and for eliminating racial and ethnic disparities; however, evaluation of vaccine acceptance by physicians and the general public should be considered before additional school-entry requirements are mandated.
In our study, there was a 4-year delay (from 5th to 9th grade) in achieving hepatitis B coverage levels of >80%. Although Illinois mandates that children who are out of compliance with vaccination requirements by October 15 be excluded from school, for minimization of the negative impact on students educational opportunities, nurses and administrators are allowed to exempt students who have initiated the 3-dose series for up to 1 year. We suspect that there may have been inconsistent enforcement of the school-entry requirement, such as extending the 1-year exemption rule. Despite the delay in vaccination, the Healthy People 2010 objective of 90% coverage was achieved by 12th grade for all white, black, and Hispanic students.
The following limitations should be considered. We evaluated Chicago public schools students, most of whom are black and many of whom are of low socioeconomic status; therefore, our findings may not generalize to other settings. Also, we required enrollment through 12th grade, and it is possible that students who left school were less likely to have been vaccinated. From 1996 through 2004, the Chicago public schools reported that the high school dropout rates ranged from 12.3% to 16.4%24; therefore, the trend for improved vaccination coverage with increasing grade may be overestimated.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Address correspondence to Julie Morita, MD, Immunization Program, Chicago Department of Public Health, 2160 W Ogden Ave, Chicago, IL 60612. E-mail: morita_julie{at}cdph.org
The authors have indicated they have no financial relationships relevant to this article to disclose.
| REFERENCES |
|---|
|
|
|---|
Read all P3Rs
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||